Literature DB >> 7431122

Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults.

L D Stegink, L J Filer, G L Baker, J E McDonnell.   

Abstract

Plasma and erythrocyte levels of free amino acids were measured in five female subjects known to be heterozygous for phenylketonuria and six subjects assumed to be normal (three male, three female) who were administered an abuse dose of aspartame (100 mg/kg) in orange juice. Small increases in plasma aspartate levels were noted 30 minutes after aspartame loading in both groups, with mean (+/- SD) levels increasing from 0.15 +/- 0.05 mumoles/100 ml to 0.43 +/- 0.23 mumoles/100 ml in normal subjects (P = 0.02), and from 0.49 +/- 0.23 mumoles/100 ml to 0.80 +/- 0.56 mumoles/100 ml in heterozygous subjects (P > 0.05). However, plasma aspartate levels remained within normal postprandial levels in each case. Erythrocyte aspartate levels were unchanged in both groups. In normal subjects, plasma phenylalanine levels (mean +/- SD) increased from fasting levels (5.40 +/- 1.05 mumoles/100 ml) to mean peak values of 20.2 +/- 6.77 mumoles/100 ml. In heterozygous subjects, mean peak plasma phenylalanine levels were approximately twice as high (41.7 +/- 2.33 mumoles/100 ml), and the area under the plasma concentration-time curve twice as large. Peak plasma phenylalanine levels, however, were below those associated with toxic effects. The data indicate slower, but adequate metabolism and clearance of an abuse dose of aspartame by the phenylketonuric heterozygote.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7431122     DOI: 10.1093/jn/110.11.2216

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  6 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note.

Authors:  R J Wurtman; T J Maher
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 3.  Inherited metabolic diseases affecting the carrier.

Authors:  W Endres
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

Review 4.  Possible neurologic effects of aspartame, a widely used food additive.

Authors:  T J Maher; R J Wurtman
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

5.  Accidental Consumption of Aspartame in Phenylketonuria: Patient Experiences.

Authors:  Ella Newbould; Alex Pinto; Sharon Evans; Suzanne Ford; Mike O'Driscoll; Catherine Ashmore; Anne Daly; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-23       Impact factor: 5.717

Review 6.  Aspartame-True or False? Narrative Review of Safety Analysis of General Use in Products.

Authors:  Kamila Czarnecka; Aleksandra Pilarz; Aleksandra Rogut; Patryk Maj; Joanna Szymańska; Łukasz Olejnik; Paweł Szymański
Journal:  Nutrients       Date:  2021-06-07       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.